Implanet S.A (ALIMP) | Stock Overview & Key Data
Implanet S.A. | Small-cap | Healthcare
Implanet S.A. | Small-cap | Healthcare
Implanet S.A Performance Comparison
Stock Range
Today's Range
Low: €0.38
High: €0.45
on October 6, 2025
52 Week Range
Low: €0.08
High: €0.45
on July 1, 2025
on October 6, 2025
All-Time High: €336.80 on February 17, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€55.4M
EPS
-0.04
P/E Ratio (TTM)
-10.92
Forward P/E
N/A
P/B Ratio
N/A
PEG Ratio
N/A
Div. Yield
N/A
ROE
-450.05%
Beta
0.965
Debt to Equity
-4.49
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-36.86%
Profit Margin
-43.35%
Returns and Earnings
Return on Assets (TTM)
-19.48%
Return on Equity (TTM)
-450.05%
EBITDA
€-4.6M
Net Income (TTM)
€-4.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.09
Quarterly Revenue Growth (YoY)
41.10%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Implanet S.A ALIMP | 55.44M Small-cap | -2.38% | 41.38% | 310.00% | 310.00% | 241.67% | 241.67% | 115.79% | -50.00% |
| Eurobio Scientific ALERS | 256.89M Mid-cap | -0.59% | -0.20% | -0.20% | 8.11% | -0.40% | -1.56% | 50.00% | 47.80% |
| Guerbet S.A GBT | 181.67M Mid-cap | 1.91% | -28.41% | -39.61% | -24.76% | -48.28% | -61.71% | -19.61% | -50.23% |
| Median Technologies ALMDT | 121.65M Small-cap | 15.28% | -5.41% | 54.42% | 26.72% | -21.70% | -9.04% | -52.84% | -59.61% |
| Affluent Medical AFME | 59.04M Small-cap | -0.68% | -2.01% | 7.35% | 11.45% | 5.04% | -14.12% | -16.57% | -81.64% |
| Diagnostic Medical ALDMS | 35.52M Small-cap | 0.00% | 3.01% | 7.87% | 55.68% | 73.42% | 69.14% | 37.00% | -12.74% |
Ownership & Short Interest
Insider Ownership
74.87%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
625K
Average 90-Day Volume
904K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALIMP's 52-week high and low?
- In the last 52 weeks, Implanet S.A reached a high of €0.45 (on October 6, 2025) and a low of €0.08 (on July 1, 2025).
- What is the market cap and P/E ratio for ALIMP?
- Curious about Implanet S.A's size and valuation? Its market capitalization stands at 55.44M. When it comes to valuation, the P/E ratio (trailing twelve months) is -10.92, and the forward P/E (looking ahead) is N/A.
- Does ALIMP pay dividends? If so, what's the yield?
- As for dividends, Implanet S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Implanet S.A's main competitors or similar companies to consider before investing?
When looking at Implanet S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurobio Scientific
ALERS256.89M Healthcare Medical Devices -1.56% 50.00% Guerbet S.A
GBT181.67M Healthcare Medical Devices -61.71% -19.61% Median Technologies
ALMDT121.65M Healthcare Medical Devices -9.04% -52.84% Affluent Medical
AFME59.04M Healthcare Medical Devices -14.12% -16.57% Diagnostic Medical
ALDMS35.52M Healthcare Medical Devices 69.14% 37.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Implanet S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Implanet S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -450.05%, the Debt to Equity ratio from the most recent quarter is -4.49, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALIMP?
- Looking at Implanet S.A's growth, its revenue over the trailing twelve months (TTM) was €11M. Compared to the same quarter last year (YoY), quarterly revenue grew by 41.10%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALIMP stock is held by insiders and institutions?
- Wondering who owns Implanet S.A stock? Company insiders (like executives and directors) hold about 74.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.